New drug shows promise for brain function in Huntington's patients
NCT ID NCT05358821
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This study tested a drug called SAGE-718 in 69 people with early Huntington's disease to see if it could improve thinking and daily functioning. Participants took the drug or a placebo for 28 days. The main goal was to measure changes in cognitive abilities like memory and problem-solving compared to healthy volunteers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUNTINGTON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sage Investigational Site
Birmingham, Alabama, 35233, United States
-
Sage Investigational Site
Los Alamitos, California, 90720, United States
-
Sage Investigational Site
Englewood, Colorado, 80113, United States
-
Sage Investigational Site
Washington D.C., District of Columbia, 20057, United States
-
Sage Investigational Site
Boca Raton, Florida, 33431, United States
-
Sage Investigational Site
Tampa, Florida, 33602, United States
-
Sage Investigational Site
Chicago, Illinois, 60612, United States
-
Sage Investigational Site
Baltimore, Maryland, 21218, United States
-
Sage Investigational Site
New York, New York, 10027, United States
-
Sage Investigational Site
Chapel Hill, North Carolina, 27599, United States
-
Sage Investigational Site
Cincinnati, Ohio, 45221, United States
-
Sage Investigational Site
Philadelphia, Pennsylvania, 19104, United States
-
Sage Investigational Site
Houston, Texas, 77030, United States
-
Sage Investigational Site
Montreal, H2X 3E4, Canada
Conditions
Explore the condition pages connected to this study.